Work

The human metapneumovirus: a case series and review of the literature

Year: 2010

Type: article

Abstract: S. Shahda, W.G. Carlos, P.J. Kiel, B.A. Khan, C.A. Hage. The human metapneumovirus: a case series and review of the literature Transpl Infect Dis 2011: 13: 324–328. All rights reserved Abstract: Human metapneumovirus (hMPV) is an emerging human pulmonary pathogen that is genetically related to respiratory syncytial virus. It has been increasingly associated with respiratory illnesses over the last few decades. Immunocompromised patients are particularly susceptible with resultant morbidity and mortality. We describe our experience with 9 immunocompromised patients diagnosed with pneumonia secondary to hMPV, 2 of whom were successfully treated with aerosolized and oral ribavirin along with intravenous immunoglobulin (IVIG). We suggest that hMPV should be considered in the differential diagnosis of immunocompromised patients with acute respiratory illness. Ribavirin (oral and aerosolized) with IVIG is potentially an effective treatment option for those with severe disease.

Source: Transplant Infectious Disease

DOI: 10.1111/j.1399-3062.2010.00575.x

Authors: S. Shahda, W.G. Carlos, P.J. Kiel, B.A. Khan, C.A. Hage